CNS Neuroscience and Therapeutics

SJR Rank #1,861H-index: 105SJR: 1.741Best quartile: Q1Open AccessAPC: US$4,140Listed in DOAJ

Journal website: aims, scope and author guidelines

Publisher

John Wiley and Sons Inc

Country

United Kingdom

Type

journal

SJR by Edition

Subject Categories

PharmacologyQ1
Pharmacology (medical)Q1
Physiology (medical)Q1
Psychiatry and Mental HealthQ1

Areas: Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Neuroinflammation and Neurodegeneration MechanismsFunctional Brain Connectivity StudiesNeuroscience and Neuropharmacology ResearchAlzheimer's disease research and treatmentsParkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNeurogenesis and neuroplasticity mechanismsNeurological Disease Mechanisms and TreatmentsEpilepsy research and treatmentAcute Ischemic Stroke Management

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

1755-5949, 1755-5930

SJR Best Quartile

Region

Western Europe

Citations per Document (2 years)

6.46

References per Document

59.89

Coverage

2008-2026

Scope

CNS Neuroscience & Therapeutics provides a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system, as well as papers related to clinical pharmacology, drug development and novel methodologies for drug evaluation. The journal focuses on neurological and psychiatric diseases such as stroke, Parkinson’s disease, Alzheimer’s disease, depression, schizophrenia, epilepsy, and drug abuse.

Metrics from SCImago Journal Rank 2025. View on SCImago